Health officials are raising the alarm over the rise of six ‘silent killers’ in the US that are becoming resistant to the drugs typically used to treat them.
A new CDC report on antimicrobial resistance threats found infections with six hard-to-treat germs had risen at least 20 percent throughout the Covid pandemic compared to 2019 and infections remained elevated through 2022, the latest year data was available.
Of particular concern was the rise of one antifungal-resistant fungus that can cause severe illness and often spreads in healthcare facilities. Cases of this, Candida auris, surged five-fold from 2019 to 2022.